Thu, May 8, 9:23 PM (7 days ago)
**Jackson Acquisition Company II (JACS.U, JACS, JACS.R) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Cash Position:** $755,968 (down from $949,366 in Q4 2024). - **Investments in Trust Account:** $235,292,200 (up from $232,858,478 in Q4 2024). - **Total Assets:** $236,280,906 (up from $234,005,881 in Q4 2024). - **Total Liabilities:** $405,164 (up from $357,540 in Q4 2024). - **Shareholders' Equity:** $583,542 (down from $789,863 in Q4 2024). **Revenue & Profit Margins:** - **Operational Costs:** $206,321. - **Net Income:** $2,227,401 (primarily from interest earned on marketable securities held in the Trust Account). - **Profit Margin:** Not applicable due to the nature of the business (blank check company). **Cash Flow:** - **Net Cash Used in Operating Activities:** ($193,398). - **Interest Earned on Marketable Securities:** $2,433,722. **Earnings Changes & Quarterly Performance:** - **Net Income per Redeemable Class A Ordinary Share:** $0.08. - **Net Income per Non-Redeemable Class A and Class B Ordinary Share:** $0.08. **Trends & Uncertainties:** - **Geopolitical Risks:** Global market volatility due to ongoing conflicts and sanctions. - **Business Combination:** Must complete a business combination within 24 months from the closing of the Initial Public Offering (December 11, 2026). - **Liquidity:** Sufficient funds for working capital needs for at least one year from the date of the financial statements. **Future Operations Impact:** - **Target Industry:** Focus on healthcare services, healthcare technology, or related industries. - **Use of Proceeds:** Substantially all of the net proceeds from the Initial Public Offering and private placement will be used to complete a business combination. - **Redemption Rights:** Shareholders have the right to redeem their shares upon the completion of a business combination or if the company does not complete a business combination within the specified time frame. **Key Metrics:** - **Cash:** $755,968 (down from $949,366 in Q4 2024). - **Investments Held in Trust Account:** $235,292,200 (up from $232,858,478 in Q4 2024). - **Operational Costs:** $206,321. - **Interest Earned on Marketable Securities:** $2,433,722. - **Net Income:** $2,227,401. **Conclusion:** Jackson Acquisition Company II is a blank check company focused on completing a business combination within the healthcare industry. The company's financial health is primarily supported by investments held in a trust account, with operational costs and interest earnings being the key drivers of its financial performance. The company faces geopolitical risks and must complete a business combination within the specified time frame to avoid liquidation.